Publication
Drug-loaded hydrogels for intraocular lenses with prophylactic action against pseudophakic cystoid macular edema
| datacite.subject.fos | Ciências Médicas | |
| datacite.subject.sdg | 03:Saúde de Qualidade | |
| dc.contributor.author | Toffoletto, Nadia | |
| dc.contributor.author | Salema-Oom, Madalena | |
| dc.contributor.author | Igea, Soledad Anguiano | |
| dc.contributor.author | Alvarez-Lorenzo, Carmen | |
| dc.contributor.author | Saramago, Benilde | |
| dc.contributor.author | Serro, Ana Paula | |
| dc.date.accessioned | 2025-09-18T11:35:17Z | |
| dc.date.available | 2025-09-18T11:35:17Z | |
| dc.date.issued | 2021-07 | |
| dc.description.abstract | Pseudophakic cystoid macular edema (PCME), caused by chronic inflammation, is the most common cause of visual impairment in the medium-term after cataract surgery. Therefore, the prophylactic topical administration of combined steroidal and non-steroidal anti-inflammatory drugs is commonly done. Drug-eluting intraocular lenses (IOLs) gained interest as an efficient way to overcome the compliance issues related to the use of ocular drops without the need for additional surgical steps. The incorporation of functional monomers and molecular imprinting were herein applied to design hydrogels suitable as IOLs and able to co-deliver steroidal (dexamethasone sodium phosphate) and non-steroidal (bromfenac sodium) drugs. The incorporation of N-(2-aminopropyl) methacrylamide (APMA) increased the drug uptake and improved the in vitro release kinetics. Imprinting with bromfenac resulted in a decreased drug release due to permanent drug bonding, while imprinting with dexamethasone increased the amount of dexamethasone released after dual-drug loading. The application of a mathematical model to predict the in vivo drug release behavior suggests the feasibility of achieving therapeutic drug concentrations of bromfenac and dexamethasone in the aqueous humor for about 2 and 8 weeks, respectively, which is compatible with the current topical prophylaxis after cataract surgery. | eng |
| dc.identifier.citation | Toffoletto N, Salema-Oom M, Anguiano Igea S, Alvarez-Lorenzo C, Saramago B, Serro AP. Drug-Loaded Hydrogels for Intraocular Lenses with Prophylactic Action against Pseudophakic Cystoid Macular Edema. Pharmaceutics. 2021; 13(7):976. https://doi.org/10.3390/pharmaceutics13070976 | |
| dc.identifier.doi | 10.3390/pharmaceutics13070976 | |
| dc.identifier.issn | 1999-4923 | |
| dc.identifier.uri | http://hdl.handle.net/10400.26/58717 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | MDPI | |
| dc.relation.hasversion | https://doi.org/10.3390/pharmaceutics13070976 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | therapeutic ophthalmic lenses | |
| dc.subject | posterior segment diseases | |
| dc.subject | drug release | |
| dc.subject | anti-inflammatory drug | |
| dc.subject | molecular imprinting | |
| dc.subject | functionalized hydrogels | |
| dc.title | Drug-loaded hydrogels for intraocular lenses with prophylactic action against pseudophakic cystoid macular edema | eng |
| dc.type | contribution to journal | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 976 | |
| oaire.citation.title | Pharmaceutics | |
| oaire.citation.volume | 13 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |